Scarica l'app Stockscreener
40.63
0.42%
-0.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$40.80
Aprire:
$40.81
Volume 24 ore:
1.63M
Relative Volume:
0.67
Capitalizzazione di mercato:
$7.65B
Reddito:
$550.17M
Utile/perdita netta:
$201.35M
Rapporto P/E:
40.63
EPS:
1
Flusso di cassa netto:
$232.07M
1 W Prestazione:
-1.53%
1M Prestazione:
-6.66%
6M Prestazione:
-33.39%
1 anno Prestazione:
-27.02%
Intervallo 1D:
$40.30
$41.13
Intervallo di 1 settimana:
$39.50
$42.13
Portata 52W:
$39.50
$85.21
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Confronta DOCS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
40.63 | 7.68B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
222.00 | 37.03B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
65.32 | 12.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
84.11 | 7.38B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.64 | 7.14B | 11.99B | 24.18M | 234.31M | 0.2956 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-01-08 | Aggiornamento | Truist | Hold → Buy |
| 2025-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-10-27 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-10-10 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Downgrade | Goldman | Neutral → Sell |
| 2025-07-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-02-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Neutral |
| 2024-11-14 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-18 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-08-09 | Downgrade | Needham | Buy → Hold |
| 2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Iniziato | Wells Fargo | Overweight |
| 2022-10-24 | Iniziato | Evercore ISI | In-line |
| 2022-10-13 | Iniziato | BTIG Research | Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Iniziato | Berenberg | Buy |
| 2022-05-18 | Reiterato | BofA Securities | Neutral |
| 2022-05-18 | Reiterato | Goldman | Buy |
| 2022-05-18 | Reiterato | Guggenheim | Buy |
| 2022-05-18 | Reiterato | Jefferies | Buy |
| 2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Reiterato | Needham | Buy |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-04 | Iniziato | BofA Securities | Neutral |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-17 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-10 | Reiterato | Canaccord Genuity | Buy |
| 2021-11-10 | Reiterato | Goldman | Neutral |
| 2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Reiterato | Needham | Buy |
| 2021-11-10 | Reiterato | Piper Sandler | Overweight |
| 2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-19 | Iniziato | Goldman | Neutral |
| 2021-07-19 | Iniziato | JP Morgan | Overweight |
| 2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Iniziato | Piper Sandler | Overweight |
| 2021-07-19 | Iniziato | Raymond James | Outperform |
| 2021-07-19 | Iniziato | SVB Leerink | Outperform |
| 2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
Assessing Doximity (DOCS) Valuation After Cautious Earnings Guidance And Guarded Investor Sentiment - Yahoo Finance
Baillie Gifford & Co. Reduces Stock Position in Doximity, Inc. $DOCS - MarketBeat
OpenEvidence, Doximity Advance Dispute Over AI Platform Access - Bloomberg Law News
Insider Trends: What is the cash position of Doximity IncTrade Risk Report & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Overweight Doximity (DOCS) Position Weighs on Fund Performance - Insider Monkey
Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell - Yahoo Finance
Aubrey Capital Management Ltd Purchases Shares of 62,500 Doximity, Inc. $DOCS - MarketBeat
Doximity (NASDAQ:DOCS) Hits New 12-Month LowHere's What Happened - MarketBeat
Doximity stock hits 52-week low at $39.92 amid challenging year - Investing.com Nigeria
Doximity stock hits 52-week low at $39.92 amid challenging year By Investing.com - Investing.com India
Wells Fargo & Company Upgrades Doximity (NYSE:DOCS) to Strong-Buy - MarketBeat
Doximity (NASDAQ:DOCS) Strengthens Professional Medical Networking - Kalkine Media
DOCS Analyst Rating Update: Wells Fargo Lowers Price Target | DO - GuruFocus
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino’s Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - AOL.com
Assessing Doximity: Insights From 9 Financial Analysts - Benzinga
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino's Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - 24/7 Wall St.
Is It Time To Reconsider Doximity (DOCS) After Recent Share Price Weakness - Sahm
Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026 - 01net
Raymond James Sees 'Knee-Jerk' AI Reaction, Reaffirms Strong Buy on Doximity, Inc. (DOCS) - Finviz
Doximity (DOCS) Is Down 13.4% After Cutting 2026 Revenue Outlook Amid Regulatory PressuresWhat's Changed - Sahm
Raymond James Sees ‘Knee-Jerk’ AI Reaction, Reaffirms Strong Buy on Doximity, Inc. (DOCS) - Insider Monkey
Raymond James sees ‘knee-jerk’ AI reaction, reaffirms strong buy on Doximity, Inc. (DOCS) - MSN
Bandwidth, Dynatrace, Paylocity, Doximity, and Agilysys Stocks Trade Down, What You Need To Know - The Globe and Mail
RSI Alert: Doximity (DOCS) Now Oversold - Nasdaq
Redlands Daily Facts - FinancialContent
3 Reasons DOCS Has Explosive Upside Potential - Finviz
Is Doximity (DOCS) Pricing Reflect Its Mixed Valuation Signals After Recent Share Price Slide - Yahoo Finance
Doximity (DOCS) Declines More Than Market: Some Information for Investors - sharewise.com
Doximity (DOCS) declines more than market: Some information for investors - MSN
Winners Losers: Will Doximity Inc stock reach Wall Street targetsJuly 2025 Intraday Action & Risk Controlled Daily Trade Plans - Bộ Nội Vụ
Here's Why Doximity (DOCS) is a Strong Growth Stock - sharewise.com
Doximity (NASDAQ:DOCS) Sets New 1-Year LowWhat's Next? - MarketBeat
Here Are Monday’s Top Wall Street Analyst Research Calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and More - AOL.com
Ad Vital Founder Dr. Shitel Patel Featured in Doximity For Expertise on Practice Sustainability - Digital Journal
Penticton Herald: FinanceDoximity (DOCS) Shares Hit 52-Week Low: Analyzing the Digital Health Downturn - FinancialContent
Doximity stock hits 52-week low at 43.17 USD By Investing.com - Investing.com Nigeria
Doximity stock hits 52-week low at 43.17 USD - Investing.com
Doximity (DOCS) Slid on Renewed Volatility - Yahoo Finance
As layoff loomed, exec turned to insider trading - Investment Executive
Volatility Watch: Will Doximity Inc stock benefit from upcoming earnings reportsOptions Play & Safe Entry Trade Reports - Bộ Nội Vụ
Doximity to settle securities litigation lawsuit for $31M - MSN
InvestingPro’s Fair Value model predicted Doximity’s 41% stock decline By Investing.com - Investing.com UK
Doximity reaches $31M settlement in securities litigation lawsuit - MSN
Understanding Momentum Shifts in (DOCS) - Stock Traders Daily
Morgan Stanley views Doximity (DOCS) underperformance as attractive entry point amid strong engagement - MSN
Morgan Stanley Views Doximity (DOCS) Underperformance as Attractive Entry Point Amid Strong Engagement - Insider Monkey
Doximity, Inc. (NYSE:DOCS) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Doximity (NYSE:DOCS) Stock Rating Upgraded by The Goldman Sachs Group - MarketBeat
Doximity (NYSE:DOCS) Raised to "Strong-Buy" at Truist Financial - MarketBeat
Morgan Stanley Stays Neutral on Doximity, Highlights Strength in Video Module Business - MSN
Doximity (NYSE:DOCS) Stock Rating Lowered by Wall Street Zen - MarketBeat
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.67%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):